Immunohistochemical and molecular analysis of spitzoid neoplasms with pulverocyte subclones

Clin Exp Dermatol. 2018 Oct;43(7):782-789. doi: 10.1111/ced.13556. Epub 2018 May 20.

Abstract

Background: Clonal naevi are characterized by a focal proliferation of pigmented melanocytes in an otherwise banal naevus. These subclones are often composed of aggregates of larger, epithelioid melanocytes with nuclear atypia and dusty-grey cytoplasmic pigmentation, which are referred to as 'pulverocytes', and this finding may lead to a misdiagnosis of malignant melanoma (MM).

Aim: To characterize the significance of subclones of dusty-grey pigmented epithelioid melanocytes within spitzoid neoplasms.

Methods: We studied the histological and molecular features of a series of 20 spitzoid neoplasms with pulverocyte subclones encountered in our practice, including both atypical Spitz tumours (ASTs) and invasive MMs.

Results: Pulverocytes were predominantly dermal, and the percentage of subclones ranged from 2% to 40%, with a median of 10% in ASTs and 25% in lesions we classified as MM. In cases with > 10% subclones, there was an increased odds of fluorescence in situ hybridization positivity (OR = 12; 95% CI 1.2-293.4; P = 0.03) and an increased odds of homozygous 9p21 deletion (OR = 3.6; 95 CI 0.28-89.82; P = 0.33), although the latter did not reach statistical significance.

Conclusions: We consider spitzoid lesions with a small subclone population to be a variant of a clonal naevus with indolent behaviour, whereas lesions with larger pulverocyte populations are more likely to have chromosomal copy number aberrations and in some cases may represent malignant transformation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Chromosome Aberrations
  • Female
  • Humans
  • Immunohistochemistry
  • In Situ Hybridization, Fluorescence
  • Male
  • Melanocytes / pathology*
  • Melanoma / pathology*
  • Middle Aged
  • Nevus, Pigmented / classification
  • Nevus, Pigmented / pathology*
  • Retrospective Studies
  • Skin Neoplasms / pathology*

Grants and funding